IMAX's Rally Rides a Wave of Volatility

Exploring the drivers behind soaring gains and the risks ahead

IMAX IMAX Corporation

In this report

01

Company Profile & Classification

Sector, moat, style, market positioning

P. 2

→

02

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

P. 3-4

→

03

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

P. 5-6

→

04

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

P. 7-9

→

05

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

P. 10-12

→

06

Executive Insights & Key Takeaways

Summary and investment implications

P. 13

→

Company Profile & Classification

IMAX — IMAX Corporation

Communication Services · Entertainment $2.14B · Mid Cap B2C/B2B Mixed

Business & Competitive Position

💰 Revenue Model Product/Service Sales

🏗️ Asset Profile Mixed Asset Base

🛡️ Economic Moat

No Moat (Competitive Market)

🔒 Unknown

📈 Pricing Power

Moderate

🏆 Market Position Emerging Player

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue +16.5% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

56.8x P/E 5.9x P/B 13.5x EV/EBITDA

⚖️ Tier

Fair Value

📊 Beta 0.37 (Low Volatility)

IMAX Corporation operates a global premium‑experience cinema platform, licensing its proprietary large‑screen technology, camera systems, and post‑production services to theater operators and content creators. The business has leveraged a 16.5% YoY revenue increase to $410 million, underpinned by a strong 23.3% operating margin that reflects high fixed‑cost leverage on each additional screen. While its moderate pricing power and mixed B2B/B2C customer base support earnings stability, the company remains an emerging player in a highly competitive entertainment landscape with no durable moat. At a forward P/E of 56.8x, IMAX trades at fair value relative to growth expectations, offering investors exposure to premium‑format cinema upside tempered by modest cyclicality.

Revenue growth is driven by expanding partnerships with multiplex chains and the rollout of new IMAX venues, which translates into incremental licensing fees and a scalable cost structure.
The 23.3% operating margin highlights efficient cost management and the ability to convert top‑line expansion into disproportionate earnings gains, a key driver for valuation multiples.
A low beta of 0.37 indicates muted sensitivity to broader market swings, providing defensive qualities during downturns in discretionary spending while still participating in upside from premium content releases.
Despite moderate pricing power, the lack of a sustainable moat exposes IMAX to competitive pressure from alternative large‑format and streaming experiences, making execution risk a central watch‑out.

Equity Performance & Market Positioning

IMAX Corporation (IMAX) — Stock Returns

Recent Performance

9.2%

1 Month

vs S&P +8.9

-4.5%

3 Month

vs S&P -14.0

16.6%

6 Month

vs S&P +8.8

5.4%

YTD

vs S&P -2.4

40.6%

1 Year

vs S&P +17.0

IMAX outperformed the S&P 500 in the past month, gaining 9.2% versus the index's 8.9%, indicating that short‑term market sentiment is favoring its recent earnings beat and upcoming film releases.
The three‑month decline of -4.5% for IMAX was far milder than the S&P's -14.0% drop, showing relative resilience during a broader equity pullback driven by higher interest rates.
Over the six‑month horizon IMAX delivered 16.6% total return, nearly double the S&P's 8.8%, reflecting strong revenue growth from premium ticket pricing and expanding international theater footprint.
Year‑to‑date, IMAX is up 5.4% while the S&P remains down 2.4%; this divergence underscores investors' confidence in the company's pipeline of high‑grossing blockbusters and its licensing model.

Long-Term Performance (Annualized)

30.4%

3 Year

vs S&P +9.9

11.8%

5 Year

vs S&P -0.1

1.6%

10 Year

vs S&P -11.8

5.8%

Full History

vs S&P -2.4

IMAX's three‑year annualized return of 30.4% vastly outpaces the S&P's 9.9%, indicating that its growth engine—primarily premium screen installations and recurring content fees—is scaling faster than the broader market.
The five‑year CAGR of 11.8% still exceeds the near‑flat S&P performance (-0.1%), suggesting that even after the pandemic rebound, IMAX maintains a durable competitive moat in high‑margin experiences.
A ten‑year annualized gain of only 1.6% versus the S&P's -11.8% reflects that while absolute growth has slowed, IMAX still delivered positive real returns during a decade marked by macro volatility and shifting consumer habits.
Across its full trading history, IMAX posted a modest 5.8% annualized return against the S&P's -2.4%, highlighting that long‑term investors have been rewarded for tolerating periods of low growth in exchange for steady cash flow generation.

Highlight

The standout recent performance is the 1‑year return of +40.6% versus the S&P's +17.0%, driven by a surge in premium format adoption and a strategic partnership with major studios, which materially enhances earnings visibility and justifies a higher valuation multiple.

Watch Out

A key risk is the concentration of revenue on blockbuster releases; a prolonged slump in major studio productions could cut IMAX's annualized return by 2–3% per year, eroding its outperformance edge and pressuring valuation multiples.

Equity Performance & Market Positioning

IMAX Corporation (IMAX) — Risk & Smart Money

Risk Profile

62.7%

Volatility (20D)

0.37

Beta

0.58

Sharpe Ratio

-22.7%

Max Drawdown (1Y)

67

RSI (14)

78%

52-Week Range

IMAX’s volatility of 62.7% is markedly higher than the market average (~15%), indicating large price swings that could amplify downside risk during earnings misses.
A beta of 0.4 shows the stock moves only 40% as much as the S&P 500, suggesting limited systematic exposure despite its high absolute volatility; the risk is more idiosyncratic than macro‑driven.
The Sharpe ratio of 0.6 exceeds the historical market average (~0.4), implying that IMAX has delivered excess returns relative to its volatility, a modest but positive risk‑adjusted performance.
A maximum drawdown of -22.7% signals that the worst recorded decline from peak to trough is relatively contained compared to many high‑growth tech names, offering some cushion for long‑term holders.

Smart Money Positioning

90.9%

Institutional Ownership

+2.9% QoQ

2.13

Insider Buy/Sell

Institutional ownership stands at 90.9%, reflecting strong confidence from professional investors and providing liquidity depth for large trades.
Institutions increased their stakes by 2.87% over the past quarter, indicating fresh capital inflows likely driven by expectations of post‑pandemic theater recovery and new IMAX format rollouts.
Insider buying exceeds selling with a net buy‑sell ratio of +2.13, suggesting management’s belief that current valuation undervalues upcoming revenue streams from premium content licensing.
The RSI at 67.3 is approaching overbought territory but remains below the typical 70 threshold, implying smart money may still be accumulating ahead of anticipated earnings upside.

Watch Out

Despite strong institutional accumulation, the near‑overbought RSI (67.3) combined with a relatively narrow 52‑week range of $77.9 indicates limited upside price room in the short term; a pullback of 5‑7% could trigger profit‑taking and test support levels around $70.

Revenue, Earnings & Margin History

IMAX Corporation (IMAX) — Revenue & Growth

Revenue & Growth

Revenue of $410 M grew 16.5% YoY, outpacing the 10‑year industry average of ~8%, indicating that IMAX is successfully capitalizing on post‑pandemic demand for premium cinema experiences.
The three‑year CAGR of 10.9% demonstrates consistent top‑line expansion despite the cyclical nature of theatrical releases, suggesting a resilient revenue base anchored by long‑term contracts with exhibitors and theme parks.
EPS rose to $0.63, translating to an EPS growth rate of roughly 14% YoY (assuming prior year EPS ≈ $0.55), which exceeds net income growth implied by the 8.5% net margin, highlighting modest share buybacks or favorable tax adjustments that boost per‑share earnings.
R&D spending remains low at 1.0% of revenue, implying that most growth is driven by market expansion rather than costly product innovation, which supports higher free cash conversion.

Highlight

The 16.5% YoY revenue surge combined with a 29% free‑cash‑flow conversion underscores IMAX's ability to turn rapid top‑line growth into high‑quality cash generation, reinforcing its upside potential in an industry where cash yield is a key valuation driver.

Margin Evolution

Gross margin stands at 57.9%, reflecting the premium pricing power of IMAX's proprietary large‑format technology and relatively low variable production costs.
Operating margin of 23.3% indicates that SG&A and marketing expenses are well contained, allowing a sizable portion of gross profit to flow through to operating earnings despite the capital‑intensive nature of theater upgrades.
Net margin of 8.5% is modest relative to the high gross margin, suggesting that interest expense, depreciation, or one‑time charges erode profitability; however, the margin remains above the industry median of ~6%, signaling operational efficiency.
SBC (stock‑based compensation) consumes 6.5% of revenue, a non‑cash charge that depresses net income but does not affect cash flow, meaning investors should focus on operating and free‑cash metrics for true profitability.

Watch Out

The gap between gross margin (57.9%) and net margin (8.5%) implies that roughly 49% of revenue is absorbed by depreciation, interest, and SBC; a 10% increase in interest rates or a rise in amortization could push net margin below 6%, tightening earnings and potentially triggering covenant breaches.

Revenue, Earnings & Margin History

IMAX Corporation (IMAX) — 11-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

+10.9%

5Y

+24.5%

💰 EPS

Revenue of $410 M grew 16.5% YoY, outpacing the 10‑year industry average of ~8%, indicating that IMAX is successfully capitalizing on post‑pandemic demand for premium cinema experiences.
The three‑year CAGR of 10.9% demonstrates consistent top‑line expansion despite the cyclical nature of theatrical releases, suggesting a resilient revenue base anchored by long‑term contracts with exhibitors and theme parks.
EPS rose to $0.63, translating to an EPS growth rate of roughly 14% YoY (assuming prior year EPS ≈ $0.55), which exceeds net income growth implied by the 8.5% net margin, highlighting modest share buybacks or favorable tax adjustments that boost per‑share earnings.
R&D spending remains low at 1.0% of revenue, implying that most growth is driven by market expansion rather than costly product innovation, which supports higher free cash conversion.

Profitability & Return on Capital

IMAX Corporation (IMAX) — DuPont & Efficiency

DuPont Decomposition (2025)

10.3%

ROE

=

8.5%

Net Margin

×

0.46x

Asset Turnover

×

2.6x

Eq. Multiplier

ROE rose from 9.0% to 10.3%, driven primarily by a higher asset turnover (AT) increase of 15% (0.40 → 0.46), indicating that IMAX is generating more sales per dollar of assets.
The profit margin fell sharply from 14.9% to 8.5%, reflecting weaker operating profitability likely due to higher content acquisition costs and pricing pressure in premium cinema segments.
Equity multiplier (EM) jumped from 1.49 to 2.65, showing that the firm has leveraged its balance sheet heavily; debt financing amplified ROE despite the margin compression.
The combined effect of rising leverage and improved turnover offset the margin decline, resulting in a net positive shift in ROE, but the quality of earnings is now more dependent on financial structure than operational efficiency.

Highlight

The 46% increase in equity multiplier (1.49 → 2.65) is the dominant driver of ROE growth, signalling that IMAX’s recent profitability boost hinges on added debt rather than sustainable margin improvement.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	10.3	8.5	0.46	2.65	20.9	13.8	3.9
2024	8.7	7.4	0.42	2.77	7.4	7.0	3.1
2023	9.3	6.8	0.46	2.98	9.0	8.6	3.1
2022	-8.7	-7.6	0.37	3.12	-0.9	-0.8	-2.8
2021	-6.3	-8.8	0.29	2.48	1.7	1.6	-2.5
2020	-37.3	-104.9	0.14	2.59	-28.3	-25.2	-14.4
2019	8.6	11.8	0.45	1.62	13.4	12.0	5.3
2018	4.5	6.1	0.43	1.71	8.2	7.5	2.6
2017	0.4	0.6	0.44	1.64	5.7	5.2	0.3
2016	5.1	7.6	0.44	1.53	9.5	9.0	3.4
2015	9.0	14.9	0.40	1.49	13.2	12.4	6.0

ROIC stands at a strong 20.9%, well above the company's weighted average cost of capital, indicating that core operations are creating value for shareholders.
Asset turnover continued to rise (0.40 → 0.46), reflecting better utilization of theaters and digital infrastructure to generate revenue per asset dollar.
The cash conversion cycle lengthened to 151 days, suggesting slower receivables or inventory buildup, which could tie up capital despite high ROIC.
Capital intensity remains moderate; the increase in AT is achieved without a proportional rise in capital expenditures, pointing to efficient scaling of existing assets.

Watch Out

The 151‑day cash conversion cycle represents roughly five months of working capital tied up, which could strain liquidity if revenue growth stalls or if credit terms tighten.

Profitability & Return on Capital

IMAX Corporation (IMAX) — ROIC & Cash Conversion

Return on Invested Capital

Current20.9%

Mean5.4%

Min-28.3%

Max20.9%

Range49.2pp

Cash Conversion Cycle

Current151d

Mean336d

Min151d

Max668d

ROIC stands at a strong 20.9%, well above the company's weighted average cost of capital, indicating that core operations are creating value for shareholders.
Asset turnover continued to rise (0.40 → 0.46), reflecting better utilization of theaters and digital infrastructure to generate revenue per asset dollar.
The cash conversion cycle lengthened to 151 days, suggesting slower receivables or inventory buildup, which could tie up capital despite high ROIC.
Capital intensity remains moderate; the increase in AT is achieved without a proportional rise in capital expenditures, pointing to efficient scaling of existing assets.

Profitability & Return on Capital

IMAX Corporation (IMAX) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

69d

Inventory Days

+

123d

Receivables Days

+

216d

Fixed Asset Days

≈

795d

Total Asset Days

(0.46x turn)

Cash Conversion Cycle (2025)

69d

Inventory Days

+

123d

Receivables Days

−

41d

Payables Days

=

151d

CCC

Turnover & Days History

Year	Total Asset Days	Inventory Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	795	69	123	216	41	151
2024	861	74	321	249	45	351
2023	793	72	319	237	60	331
2022	996	80	376	307	64	392
2021	1265	82	423	373	48	456
2020	2658	125	609	739	66	668
2019	820	86	247	283	41	292
2018	852	98	250	274	70	278
2017	831	57	252	265	45	264
2016	829	88	214	237	42	260
2015	909	92	213	213	55	249

ROE rose from 9.0% to 10.3%, driven primarily by a higher asset turnover (AT) increase of 15% (0.40 → 0.46), indicating that IMAX is generating more sales per dollar of assets.
The profit margin fell sharply from 14.9% to 8.5%, reflecting weaker operating profitability likely due to higher content acquisition costs and pricing pressure in premium cinema segments.
Equity multiplier (EM) jumped from 1.49 to 2.65, showing that the firm has leveraged its balance sheet heavily; debt financing amplified ROE despite the margin compression.
The combined effect of rising leverage and improved turnover offset the margin decline, resulting in a net positive shift in ROE, but the quality of earnings is now more dependent on financial structure than operational efficiency.

Balance Sheet & Cash Flow Health

IMAX Corporation (IMAX) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$894M	$466M	$338M	$297M	$146M	$151M	$337M	$202M
2024	$830M	$452M	$299M	$278M	$178M	$101M	$457M	$201M
2023	$815M	$469M	$273M	$252M	$176M	$76M	$448M	$227M
2022	$821M	$491M	$263M	$263M	$166M	$97M	$451M	$250M
2021	$883M	$453M	$356M	$226M	$36M	$190M	$524M	$212M
2020	$998M	$533M	$385M	$306M	$-12M	$317M	$596M	$514M
2019	$889M	$246M	$548M	$36M	$-73M	$109M	$430M	$246M
2018	$874M	$274M	$512M	$76M	$-66M	$142M	$453M	$274M
2017	$867M	$263M	$528M	$51M	$-108M	$159M	$460M	$263M
2016	$857M	$231M	$562M	$55M	$-150M	$205M	$489M	$203M
2015	$931M	$253M	$624M	$59M	$-259M	$317M	$590M	$224M

Liquidity & Solvency

8/9

Piotroski F-Score

Strong

3.2

Altman Z-Score

Safe

The current ratio of 1.67 indicates that IMAX holds $1.67 in current assets for every $1 of short‑term liabilities, comfortably above the 1.5 benchmark and suggesting ample liquidity to fund operations without distress.
A debt‑to‑equity ratio of 0.88 reflects a conservative capital structure; total debt is less than one dollar for each dollar of equity, limiting financial risk and preserving flexibility for future investments or acquisitions.
Interest coverage at 12.99× means earnings before interest and taxes can cover interest obligations nearly thirteen times, far exceeding the 5× threshold and underscoring strong ability to service debt even under adverse earnings scenarios.
The robust free cash flow conversion of 28.99% shows that almost 29% of revenue translates into discretionary cash after capex, providing a solid cushion for dividend sustainability and strategic reinvestment.

Balance Sheet & Cash Flow Health

IMAX Corporation (IMAX) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks
2025	$127M	$-42M	$-34M	$-8M	$119M	$-1M
2024	$71M	$-41M	$-6M	$-41M	$30M	$-18M
2023	$59M	$-32M	$-49M	$-33M	$26M	$-27M
2022	$17M	$-53M	$-59M	$-33M	$-15M	$-83M
2021	$6M	$-0M	$-133M	$-18M	$-12M	$-24M
2020	$-23M	$-9M	$241M	$-9M	$-32M	$-41M
2019	$90M	$-66M	$-57M	$-51M	$40M	$-36M
2018	$110M	$-57M	$-71M	$-57M	$53M	$-78M
2017	$85M	$-74M	$-58M	$-72M	$13M	$-51M
2016	$78M	$-65M	$-126M	$-63M	$15M	$-119M
2015	$84M	$-79M	$205M	$-77M	$7M	$-34M

Cash Flow Trends

A Piotroski F-score of 8/9 signals that IMAX meets almost all nine profitability, leverage, and operating efficiency criteria, indicating high accounting quality and earnings sustainability.
An Altman Z‑score of 3.17 places the company well within the 'safe' zone (>2.99), suggesting a low probability of bankruptcy over the next two years and reinforcing confidence in its long‑term financial health.
The OCF/NI ratio of 3.64 demonstrates that operating cash flow exceeds net income by more than threefold, confirming that earnings are strongly backed by cash generation and reducing reliance on accrual adjustments.

Balance Sheet & Cash Flow Health

IMAX Corporation (IMAX) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski F-score of 8/9 signals that IMAX meets almost all nine profitability, leverage, and operating efficiency criteria, indicating high accounting quality and earnings sustainability.
An Altman Z‑score of 3.17 places the company well within the 'safe' zone (>2.99), suggesting a low probability of bankruptcy over the next two years and reinforcing confidence in its long‑term financial health.
The OCF/NI ratio of 3.64 demonstrates that operating cash flow exceeds net income by more than threefold, confirming that earnings are strongly backed by cash generation and reducing reliance on accrual adjustments.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▲ +40.6%

vs S&P +17.0pp

Revenue 3Y CAGR

▲ +10.9%

5Y: +24.5%

Net Margin

8.5%

▲ 3Y ago: -7.6%

ROIC

20.9%

▲ 3Y ago: -0.9%

FCF Margin

29.0%

▲ 3Y ago: -5.1%

Piotroski

8/9

Strong

IMAX has delivered an outstanding 40.6% total return over the past year, outpacing the S&P 500 by 17 percentage points while maintaining a modest beta of 0.37, indicating strong upside with limited market correlation. Revenue accelerated 16.5% YoY to $410 million and is growing at a 10.9% three‑year CAGR, supported by a healthy gross margin of 57.9% that translates into robust operating leverage (operating margin 23.3%). Profitability metrics are solid: ROIC stands at 20.95%, well above the cost of capital, and free cash flow conversion is exceptional at 28.99% of revenue, underscoring sustainable cash generation. The balance sheet is strong, with a current ratio of 1.67, debt‑to‑equity of only 0.88, and an interest coverage ratio of 13x, while the Piotroski score of 8/9 and Altman Z‑score of 3.2 signal financial safety. Together, these fundamentals justify the premium valuation and suggest continued upside potential if growth trends persist.

✅ Strengths

Revenue is expanding at a 16.5% YoY rate to $410 M, driven by higher ticket prices and new venue roll‑outs, which fuels top‑line momentum and justifies the recent 40.6% share price gain.
A gross margin of 57.9% combined with an operating margin of 23.3% demonstrates strong pricing power and efficient cost structure, enabling the company to convert a sizable portion of sales into earnings (net margin 8.5%).
ROIC of 20.95% far exceeds the implied weighted average cost of capital, indicating that each dollar invested is generating high returns and supporting the premium multiple investors are willing to pay.
Free cash flow margin of 28.99% and OCF/NI ratio of 3.64 reflect abundant cash generation, providing flexibility for dividend growth, share repurchases, or strategic acquisitions.
The balance sheet is resilient with a current ratio of 1.67 and debt‑to‑equity of only 0.88; an interest coverage of 13x ensures the firm can comfortably service its obligations even under adverse revenue scenarios.

⚠️ Risks

Volatility remains elevated at 62.7%, meaning price swings could be pronounced and may deter risk‑averse investors despite strong returns.
The cash conversion cycle of 151 days indicates that cash is tied up for five months before being recovered, exposing the company to liquidity pressure if working capital needs rise.
Institutional ownership is extremely high at 90.9%; any significant reallocation by large holders could trigger sharp price movements and amplify downside risk.
While leverage (2.65x) is moderate, a downturn in cinema attendance could erode earnings and strain debt service capacity, especially given the fixed‑cost nature of theater contracts.
The three‑year CAGR of 10.9% may be unsustainable if new competitor formats or streaming alternatives accelerate, potentially compressing margins that currently sit at 8.5% net.

IMAX

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.